Biotech

All Articles

Turnstone gives up 60%, agitates C-suite to extend cash money

.Turnstone Biologics is lowering its head count by 60% and shocking its C-suite in order to always k...

Gilead quits on $15M MASH wager after reviewing preclinical data

.In a year that has actually observed an authorization and also a plethora of readouts for metabolic...

Texas biotech centers cancer contract, pins really hopes on being overweight

.Alaunos Rehabs is actually axing a deal with Precigen, losing hope licensing legal rights to an ind...

Capricor portions extra records for DMD treatment after starting BLA

.Capricor Therapeutics is taking a success tour for their stage 2 Duchenne muscle dystrophy (DMD) tr...

FDA spots Kezar lupus test in grip observing 4 individual fatalities

.The FDA has actually positioned Kezar Life Sciences' lupus trial on grip after the biotech hailed 4...

Phase 3 Intellectual Stone test hits SMA objective, sending out stock up 200%

.A period 3 trial of Scholar Rock's back muscle degeneration (SMA) applicant has actually hit its ow...

CAMP 4 is most current to eye IPO, while Upstream spells out $182M plan

.RNA biotech CAMP4 Therapies has defined prepare for a $67 thousand IPO, along with inflammation-foc...

Galecto acquires leukemia drug, drops bone cancer cells resource in pivot

.A year after the failure of an idiopathic pulmonary fibrosis applicant delivered Galecto on a seek ...

Judo throws down $100M to knock out kidney disease

.Taking the floor covering is Judo Biography, an ambitious biotech armed along with $one hundred tho...

AstraZeneca pays for CSPC $100M for preclinical heart disease drug

.AstraZeneca has actually paid CSPC Pharmaceutical Group $one hundred thousand for a preclinical hea...